Breaking News

Pall Corporation wins supply contract with Servier

The filtration specialist will supply exclusive tech and services to Servier's new biomanufacturing site in France

AveXis chooses BIA Separations for support on gene therapy pipeline

BIA Separations will provide the Novartis company expertise in next-gen biomolecule purification processes and ...

Abcam enters cell editing market through acquisition of EdiGene

China-based EdiGene has developed the industry’s largest off-the-shelf diploid library of over 2,800 single clonal ...

Video: Screening and processing systems for powder coatings

The industrial vibratory screener by Russell Finex automatically screens powder coatings, removing all contamination ...

Legacy ramps up preparations for Russian track-and-trace regulations

Swiss pharma supplier has installed and certified new Bosch serialisation and aggregation equipment on three packaging ...

UK trials subscription-style scheme to lure pharma into drug development

The initiative pays pharmaceuticals upfront for access to drugs based on their usefulness to the NHS

Seal selection for pump optimisation

Process containment and reducing the risk of product contamination are key requisites for pharmaceutical production ...

Low doses of radiation promote cancer-capable cells

A new study has shown that low doses of radiation weigh the odds in favour of cancer-capable mutant cells in the ...

Vitamin K2 technology wins award for NattoPharma spin-off

Kaydence Pharma has received a start-up award at the BIO International convention

Industrial coatings company chooses ABB Ability to achieve zero downtime

Transcontinental Advanced Coatings has piloted ABB's system on equipment at its Wrexham facility

Taking a multifaceted approach to combatting superbugs

It was welcome news to hear that scientists had recently discovered a new compound that could pave the way for much- ...

Process optimisation with flow chemistry

WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more ...

Ilya Pharma takes minibioreactor wound care biologic into the clinic

Swedish MPA approves first-in-human trial of Ilya Pharma’s first-in-class ILP100 topical wound care therapy

Kite to build plant for cell therapies portfolio in California

A 67,000-square-foot facility will be built within an existing Gilead biologics production site in Oceanside